Roquefort Therapeutics PLC (LSE:ROQ, OTCQB:ROQAF) chief executive Ajan Reginald speaks to Proactive's Thomas Warner after announcing the biotech company has developed a new platform of potential anti-cancer messenger RNA (mRNA) therapeutics.
Reginald reveals the reasons for the move, saying that "developing cutting edge medicines using innovative new approaches" is "what Roquefort is all about."
Contact Details
Proactive UK Ltd
+44 20 7989 0813
